AT329531B - Verfahren zur herstellung von neuen hydroxycitronensaure-gamma-lactonderivaten - Google Patents

Verfahren zur herstellung von neuen hydroxycitronensaure-gamma-lactonderivaten

Info

Publication number
AT329531B
AT329531B AT1024072A AT1024072A AT329531B AT 329531 B AT329531 B AT 329531B AT 1024072 A AT1024072 A AT 1024072A AT 1024072 A AT1024072 A AT 1024072A AT 329531 B AT329531 B AT 329531B
Authority
AT
Austria
Prior art keywords
hydroxycitronic
gamma
preparation
acid
new
Prior art date
Application number
AT1024072A
Other languages
German (de)
English (en)
Other versions
ATA1024072A (de
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to AT159775A priority Critical patent/AT330140B/de
Publication of ATA1024072A publication Critical patent/ATA1024072A/de
Application granted granted Critical
Publication of AT329531B publication Critical patent/AT329531B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT1024072A 1971-12-02 1972-12-01 Verfahren zur herstellung von neuen hydroxycitronensaure-gamma-lactonderivaten AT329531B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT159775A AT330140B (de) 1971-12-02 1975-02-28 Verfahren zur herstellung von neuen derivaten des acyloxycitronensaure-gamma-lactons und von deren salzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20428871A 1971-12-02 1971-12-02

Publications (2)

Publication Number Publication Date
ATA1024072A ATA1024072A (de) 1975-08-15
AT329531B true AT329531B (de) 1976-05-10

Family

ID=22757336

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1024072A AT329531B (de) 1971-12-02 1972-12-01 Verfahren zur herstellung von neuen hydroxycitronensaure-gamma-lactonderivaten

Country Status (12)

Country Link
US (1) US3767678A (forum.php)
JP (1) JPS4862720A (forum.php)
AT (1) AT329531B (forum.php)
AU (1) AU473724B2 (forum.php)
BE (1) BE792180A (forum.php)
CA (1) CA994336A (forum.php)
DE (1) DE2258255A1 (forum.php)
ES (1) ES409191A1 (forum.php)
FR (1) FR2162012B1 (forum.php)
GB (1) GB1374347A (forum.php)
NL (1) NL7216120A (forum.php)
ZA (1) ZA728402B (forum.php)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007208A (en) * 1973-07-05 1977-02-08 Hoffmann-La Roche Inc. Hydroxycitric acid derivatives
US4006166A (en) * 1973-07-05 1977-02-01 Hoffmann-La Roche Inc. Hydroxycitric acid derivatives
US6770782B1 (en) * 1995-05-15 2004-08-03 Sabinsa Corporation Process for the production of potassium hydroxy citric acid, and compositions containing the potassium hydroxy citric acid
US6160172A (en) 1997-08-27 2000-12-12 Vittal Mallya Scientific Research Foundation Soluble double metal salt of group IA and IIA of (-) hydroxycitric acid, process of preparing the same and its use in beverages and other food products without effecting their flavor and properties
US6503905B1 (en) * 1998-12-29 2003-01-07 Pfizer Inc 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
US7015250B2 (en) * 2000-02-09 2006-03-21 Glykon Technologies Group, Llc Methods and pharmaceutical preparations for normalizing blood pressure with (-)-hydroxycitric acid
US6476071B1 (en) 2001-05-07 2002-11-05 Dallas L. Clouatre Correcting polymorphic metabolic dysfunction with (−)-hydroxycitric acid
US6441041B1 (en) 2001-06-20 2002-08-27 Dallas L. Clouatre (-)-hydroxycitric acid for the prevention of osteoporosis
US6482858B1 (en) 2001-06-20 2002-11-19 Dallas L Clouatre (−)-hydroxycitric acid for wound healing and immunomodulation
US8394856B2 (en) * 2002-07-02 2013-03-12 Glykon Technologies Group, Llc (-)-Hydroxycitric acid for controlling inflammation
US20050009919A1 (en) * 2003-07-07 2005-01-13 Clouatre Dallas L. Treating cachexia and excessive catabolism with (-)-hydroxycitric acid
US20060025483A1 (en) * 2004-07-29 2006-02-02 Clouatre Dallas L (-)-Hydroxycitric acid for protection against soft tissue and arterial calcification
US20060025482A1 (en) * 2004-07-29 2006-02-02 Clouatre Dallas L (-)-Hydroxycitric acid for the modulation of angiotensin-converting enzyme

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758122A (fr) * 1969-10-29 1971-04-28 Hoffmann La Roche Procede pour la fabrication d'une preparation pharmaceutique

Also Published As

Publication number Publication date
ATA1024072A (de) 1975-08-15
ES409191A1 (es) 1976-01-01
US3767678A (en) 1973-10-23
AU473724B2 (en) 1976-07-01
AU4936172A (en) 1974-05-30
FR2162012B1 (forum.php) 1975-10-17
JPS4862720A (forum.php) 1973-09-01
DE2258255A1 (de) 1973-06-07
GB1374347A (en) 1974-11-20
ZA728402B (en) 1973-07-25
CA994336A (en) 1976-08-03
BE792180A (fr) 1973-06-01
NL7216120A (forum.php) 1973-06-05
FR2162012A1 (forum.php) 1973-07-13

Similar Documents

Publication Publication Date Title
AT313268B (de) Verfahren zur Herstellung von neuen 5-Aroylpyrrolderivaten
AT322550B (de) Verfahren zur herstellung von neuen isothiocyanobenzazolen
AT318610B (de) Verfahren zur Herstellung von neuen Carboxamidotetrazol-Derivaten
AT319607B (de) Verfahren zur Herstellung von neuen Polyepoxydpolysiloxanverbindungen
AT316763B (de) Verfahren zur Herstellung von neuen Adenosinderivaten
AT321476B (de) Verfahren zur Herstellung von neuen Adenosinderivaten
AT314533B (de) Verfahren zur Herstellung von neuen Oxadiazolonderivaten
AT329531B (de) Verfahren zur herstellung von neuen hydroxycitronensaure-gamma-lactonderivaten
AT309398B (de) Verfahren zur Herstellung von neuen 1-Crotonylcyclohex-2-enen
AT315201B (de) Verfahren zur Herstellung von neuen α-Alkoxy-ω-siloxanolen
AT317891B (de) Verfahren zur Herstellung von neuen substituierten 3-Benzylpyridinverbindungen
AT315837B (de) Verfahren zur Herstellung von neuen Thiazolidinderivaten
AT319245B (de) Verfahren zur Herstellung von neuen Pyridinderivaten
AT317212B (de) Verfahren zur Herstellung von neuen Benzopyranderivaten
AT319953B (de) Verfahren zur Herstellung von neuen substituierten Isazolopyrimidinen
AT316748B (de) Verfahren zur Herstellung von neuen Lincomycinderivaten
AT315196B (de) Verfahren zur Herstellung von neuen 6-Hydroxy-dihydro-uracilen
AT321309B (de) Verfahren zur Herstellung von neuen substituierten Isoxazolopyrimidinen
AT310771B (de) Verfahren zur Herstellung von neuen Phosphinyl-alkylaminobenzophenonen
AT315373B (de) Verfahren zur Herstellung von neuen 3-Formylrifamycin-SV-Derivaten
AT319203B (de) Verfahren zur Herstellung von neuen N-Acetyl-S-(3-aryl-3-oxopropyl)-cysteinderivaten
AT313897B (de) Verfahren zur Herstellung von neuen Oxadiazolonderivaten
AT310761B (de) Verfahren zur Herstellung von neuen Triazolobenzodiazepin-5N-oxyd-Derivaten
AT320662B (de) Verfahren zur Herstellung von neuen Carbamoyloximen
AT317903B (de) Verfahren zur Herstellung von neuen Pyrimidotriazinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee